Hapvida Participacoes e Investimentos (HAPV3) Q2 2024 earnings summary

Executive summary

• Achieved strong operational and financial performance in Q2 2024, with significant improvements in margins and cash generation, driven by verticalization, integration, disciplined portfolio management, and cost control.

• Net revenue grew 4.5% year-over-year to R$7,150.4 million in Q2 2024, driven by higher average ticket prices despite a decline in beneficiaries.

• Adjusted EBITDA surged 58.0% year-over-year to R$957.9 million (13.4% margin) in Q2 2024, reflecting effective price adjustments and cost control.

• Integration phases completed in São Paulo, Rio de Janeiro, and Minas Gerais, enhancing network efficiency, quality, and customer experience.

• Launched new products targeting retail and small businesses, expanded own network through new hospital projects and BTS financing, and completed divestments in non-core businesses.

Financial highlights

• Consolidated net revenue reached R$7,150.4 million in Q2 2024 (up 4.5% year-over-year) and R$14,142 million in H1 2024 (up 4.2%).

• Adjusted EBITDA was R$957.9 million in Q2 2024 (13.4% margin), up 58.0% year-over-year; H1 2024 Adjusted EBITDA was R$1,969.5 million (13.9% margin), up 58.7%.

• Adjusted net income rose 121.2% year-over-year in Q2 2024 to R$490.2 million.

• Free cash flow was R$307.4 million in Q2 2024, with cash generation at 56.3% of Adjusted EBITDA.

• Net debt reduced to R$4,348.4 million (1.03x EBITDA), down from R$4,392.3 million (1.13x) in Q1 2024.

Outlook and guidance

• Optimistic about organic growth as gross sales exceeded cancellations for the first time since early 2023.

• Continued focus on margin recovery, cost control, and verticalization, with ongoing investments in network expansion and technology.

• CapEx for 2024 projected at around R$700 million, with freed-up capital from BTS transactions enabling acceleration of network expansion.

• No material impacts from climate change or tax reform identified as of June 30, 2024.